Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
Neuropsychopharmacology
; 47(5): 1088-1095, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34839364
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depressive Disorder, Treatment-Resistant
/
Ketamine
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Neuropsychopharmacology
Journal subject:
NEUROLOGIA
/
PSICOFARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: